A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis

Objective: To prepare a novel nanoemulsion- Carbopol® 934 gel for Eugenol, in order to prevent the periodontitis. Material and methods: Spontaneous emulsification method was used for the preparation of nanoemulsion in which it contain Eugenol (oil phase), Tween-80 (surfactant), and PEG (co-surfactan...

Full description

Bibliographic Details
Main Authors: Niyaz Ahmad, Farhan Jalees Ahmad, Sumit Bedi, Sonali Sharma, Sadiq Umar, Mohammad Azam Ansari
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Saudi Pharmaceutical Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016419300702
id doaj-8e4de1b66652485295f79d2d8bb5a3e5
record_format Article
spelling doaj-8e4de1b66652485295f79d2d8bb5a3e52020-11-25T02:13:09ZengElsevierSaudi Pharmaceutical Journal1319-01642019-09-01276778790A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitisNiyaz Ahmad0Farhan Jalees Ahmad1Sumit Bedi2Sonali Sharma3Sadiq Umar4Mohammad Azam Ansari5Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia; Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia; Corresponding author at: Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.Nanomedicine Lab, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDivision of Pediatric Dentistry, Department of Preventive Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi ArabiaDepartment of Biomedical Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi ArabiaDivision of Rheumatology, Department of Medicine, University of Illinois, Chicago, IL, USADepartment of Epidemic Disease Research, Institutes of Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi ArabiaObjective: To prepare a novel nanoemulsion- Carbopol® 934 gel for Eugenol, in order to prevent the periodontitis. Material and methods: Spontaneous emulsification method was used for the preparation of nanoemulsion in which it contain Eugenol (oil phase), Tween-80 (surfactant), and PEG (co-surfactant). To the development of best nanoemulsion, three-factor three-level central composite design was used in which %oil; %Smix and % water were optimized as independent variables. An optimized–nanoemulsion were converted to nanoemulsion–Carbopol® 934 gel. Results: 5.5% oil, 35.5% Smix and 59.0% water were optimized as independent and dependent variables. Finally dependent variables optimized as a particle size (nm), PDI and %transmittance were observed 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31% respectively. The values of final results for dependent variables like particle size (nm), PDI and % transmittance were evaluated as 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31%, respectively. TEM and SEM showed a spherical shape of developed nanoemulsion with refractive index (1.63 ± 0.038), zeta potential (−19.16 ± 0.11), pH (7.4 ± 0.06), viscosity (34.28 ± 6 cp), and drug content of 98.8 ± 0.09%. After that a final optimized EUG–NE–Gel was assessed on the basis of their pH measurement, drug content, syringeability, and mucoadhesion on the goat buccal mucosa. Optimized EUG-NE-Gel (Tween-80 and Carbopol® 934 used) showed the results, to improve the periodontal drug delivery of EUG in future. Conclusion: EUG-NE-Gel showed a significant role in anti-inflammatory activity, analgesic, and anesthetic, antibacterial, and treatment of periodontal disease. Keywords: Eugenol, Nanoemulsion–gel, Mucoadhesion, Anti-inflammatory & periodontal diseasehttp://www.sciencedirect.com/science/article/pii/S1319016419300702
collection DOAJ
language English
format Article
sources DOAJ
author Niyaz Ahmad
Farhan Jalees Ahmad
Sumit Bedi
Sonali Sharma
Sadiq Umar
Mohammad Azam Ansari
spellingShingle Niyaz Ahmad
Farhan Jalees Ahmad
Sumit Bedi
Sonali Sharma
Sadiq Umar
Mohammad Azam Ansari
A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
Saudi Pharmaceutical Journal
author_facet Niyaz Ahmad
Farhan Jalees Ahmad
Sumit Bedi
Sonali Sharma
Sadiq Umar
Mohammad Azam Ansari
author_sort Niyaz Ahmad
title A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
title_short A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
title_full A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
title_fullStr A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
title_full_unstemmed A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
title_sort novel nanoformulation development of eugenol and their treatment in inflammation and periodontitis
publisher Elsevier
series Saudi Pharmaceutical Journal
issn 1319-0164
publishDate 2019-09-01
description Objective: To prepare a novel nanoemulsion- Carbopol® 934 gel for Eugenol, in order to prevent the periodontitis. Material and methods: Spontaneous emulsification method was used for the preparation of nanoemulsion in which it contain Eugenol (oil phase), Tween-80 (surfactant), and PEG (co-surfactant). To the development of best nanoemulsion, three-factor three-level central composite design was used in which %oil; %Smix and % water were optimized as independent variables. An optimized–nanoemulsion were converted to nanoemulsion–Carbopol® 934 gel. Results: 5.5% oil, 35.5% Smix and 59.0% water were optimized as independent and dependent variables. Finally dependent variables optimized as a particle size (nm), PDI and %transmittance were observed 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31% respectively. The values of final results for dependent variables like particle size (nm), PDI and % transmittance were evaluated as 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31%, respectively. TEM and SEM showed a spherical shape of developed nanoemulsion with refractive index (1.63 ± 0.038), zeta potential (−19.16 ± 0.11), pH (7.4 ± 0.06), viscosity (34.28 ± 6 cp), and drug content of 98.8 ± 0.09%. After that a final optimized EUG–NE–Gel was assessed on the basis of their pH measurement, drug content, syringeability, and mucoadhesion on the goat buccal mucosa. Optimized EUG-NE-Gel (Tween-80 and Carbopol® 934 used) showed the results, to improve the periodontal drug delivery of EUG in future. Conclusion: EUG-NE-Gel showed a significant role in anti-inflammatory activity, analgesic, and anesthetic, antibacterial, and treatment of periodontal disease. Keywords: Eugenol, Nanoemulsion–gel, Mucoadhesion, Anti-inflammatory & periodontal disease
url http://www.sciencedirect.com/science/article/pii/S1319016419300702
work_keys_str_mv AT niyazahmad anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT farhanjaleesahmad anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT sumitbedi anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT sonalisharma anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT sadiqumar anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT mohammadazamansari anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT niyazahmad novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT farhanjaleesahmad novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT sumitbedi novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT sonalisharma novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT sadiqumar novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
AT mohammadazamansari novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis
_version_ 1724905973836939264